Cardiome Pharma Corp. (CRME)

2.08
0.02 0.95
NASDAQ : Health Technology
Prev Close 2.10
Open 2.16
Day Low/High 2.08 / 2.17
52 Wk Low/High 1.29 / 4.84
Volume 35.32K
Avg Volume 163.40K
Exchange NASDAQ
Shares Outstanding 31.88M
Market Cap 81.99M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For Cardiome Pharma (CRME)

Oversold Conditions For Cardiome Pharma (CRME)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiome Pharma Becomes Oversold (CRME)

Cardiome Pharma Becomes Oversold (CRME)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiome Pharma is Now Oversold (CRME)

Cardiome Pharma is Now Oversold (CRME)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiome Pharma Corporation Stock Downgraded (CRME)

Cardiome Pharma Corporation Stock Downgraded (CRME)

Cardiome Pharma Corporation (Nasdaq:CRME) has been downgraded by TheStreet Ratings from from a hold to sell.

Ratings Changes Today

Upgrades: AIRI, EGAS, GBNK, GTWN, KNL, TPLM Downgrades: CRME, CSBK, GORO, GYRO, REED, SBGI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

Upgrades: BBW, CMSB, COR, CRME, DLR, EXC, EXL, MSON, NCIT, O, OWW, PKE, PRCP, ROVI, STS, WRI Downgrades: AEM, APA, BAK, CIX, DLLR, EXPR, KOP, LPX, PZZI, SKYW Initiations: RKUS Read on to get TheStreet Quant Ratings' detailed report:

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

4 Stocks Under $10 in Breakout Territory

4 Stocks Under $10 in Breakout Territory

These under-$10 stocks are within range of triggering breakout trades.

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Keep these under-$10 stocks on your radar.

Ratings Changes Today

Upgrades: BMRN, CSPI, DLPH, GSB, QGEN, RCKY, RDEN, SCLN, SGOC, VAC, WOOF Downgrades: ATAX, BONA, CMLP, CRME, EGAS, FORR, FULL, KRNY, PCYG, QSII, VHI Initiations: ALEX, CZR, INSY, LGP, MCBK, USMD, WDAY Read on to get TheStreet Quant Ratings' detailed report:

Cardiome Pharma Corporation Stock Upgraded (CRME)

Cardiome Pharma Corporation Stock Upgraded (CRME)

Cardiome Pharma Corporation (Nasdaq:CRME) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: CRME, PICO Downgrades: CIG, ISRG, OBCI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Cardiome To Hold Conference Call

Cardiome To Hold Conference Call

Cardiome To Hold Investor Update Call

Cardiome To Hold Investor Update Call

5 Under-$10 Stocks Set to Soar

5 Under-$10 Stocks Set to Soar

These volatile stocks could pay off big in the near term.

Cardiome Pharma Corp. (CRME): Today's Featured Health Care Loser

Cardiome Pharma Corp. (CRME): Today's Featured Health Care Loser

Cardiome Pharma was a leading decliner within the health care sector, falling 10 cents (-2.9%) to $3.32 on average volume.

Cardiome Pharma Corp. Stock Downgraded (CRME)

Cardiome Pharma Corp. Stock Downgraded (CRME)

Cardiome Pharma Corp (Nasdaq:CRME) has been downgraded by TheStreet Ratings from from a hold to sell.

Cardiome Stock Gaps Up On Today's Open (CRME)

Cardiome Stock Gaps Up On Today's Open (CRME)

Shares of Cardiome Pharma Corp (Nasdaq:CRME) were gapping up Tuesday morning with an open price 12% higher than Monday's closing price. The stock closed at $4.34 yesterday and opened today's trading at $4.86.

Cardiome Pharma Corp. Stock Upgraded (CRME)

Cardiome Pharma Corp. Stock Upgraded (CRME)

Cardiome Pharma Corp (Nasdaq:CRME) has been upgraded by TheStreet Ratings from a sell to hold.

Cardiome Pharma Corp. Stock Downgraded (CRME)

Cardiome Pharma Corp. Stock Downgraded (CRME)

Cardiome Pharma Corp (Nasdaq:CRME) has been downgraded by TheStreet Ratings from from a hold to sell.

Cardiome Stock Soars (CRME)

Cardiome Stock Soars (CRME)

Shares of Cardiome Pharma Corp (Nasdaq:CRME) have taken a tremendous swing upward. The stock is trading at $5.30 as of 3:51 p.m. ET, 20.2% above Tuesday's closing price of $4.41. Volume is at 1.1 million, 4.8 times the daily average of 231,600.

Graymark, Orexigen: Volume Movers

Graymark, Orexigen: Volume Movers

Several stocks trading near $5, including Graymark Healthcare, were poised to move on above-average volume Thursday.

Cardiome Jumps on Drug Progress

Shares of Cardiome Pharma starred after the closing bell as the company and partner Merck disclosed a marketing approval related to their Brinavess cardiovascular drug.

BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation

BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation

Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp.